Cargando…
Is intraocular pressure reduction the key treatment for normal-tension glaucoma?
Autor principal: | Chen, Mei-Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787095/ https://www.ncbi.nlm.nih.gov/pubmed/33437594 http://dx.doi.org/10.4103/tjo.tjo_71_20 |
Ejemplares similares
-
Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects with Normal Tension Glaucoma
por: Naito, Tomoko, et al.
Publicado: (2016) -
Effect of travoprost on 24-hour intraocular pressure in normal tension glaucoma
por: Nomura, Yuya, et al.
Publicado: (2010) -
Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma
por: Ikeda, Yoko, et al.
Publicado: (2016) -
Circadian Blood Pressure and Intraocular Pressure Patterns in Normal Tension Glaucoma Patients with Undisturbed Sleep
por: Kim, Yong-Kyu, et al.
Publicado: (2010) -
Circadian Patterns of Intraocular Pressure Fluctuation among Normal-Tension Glaucoma Optic Disc Phenotypes
por: Moon, Yeji, et al.
Publicado: (2016)